Endocrine Abstracts

Introduction: Despite the significant associated cardiovascular morbidity, as well as the significant economic implications, little consideration has been given towards population screening for the Metabolic Syndrome (MetS). Therefore, we wished to estimate the prevalence of MetS, using both the recently published IDF, as well as the previously defined Cholesterol Education Program Adult Treatment Panel III (ATPIII), criteria. Additionally, we hypothesised that simple, inexpen...

Introduction: The presence of Metabolic Syndrome (MetS) may be associated with increased cardiovascular risk. The International Diabetes Foundation (IDF) has recently published new diagnostic criteria for MetS. Thus, we sought to compare IDF-defined MetS, the previously defined Cholesterol Education Program Adult Treatment Panel III (ATPIII) and the European SCORE risk stratification model as predictors of the presence of Ischaemic Heart Disease (IHD) within an asymptomatic po...